IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia | Zendy

Gamze Güney Eskiler | Zendy; Erhan BEZDEGÜMELİ | Zendy; Zeynep Özman | Zendy; Asuman Deveci Özkan | Zendy; Cemil Bilir | Zendy; Bilge Nur Küçükakça | Zendy; Merve İnce | Zendy; Angela Men | Zendy; O. Aktas | Zendy; Y. E. Horoz | Zendy; Denizhan Akpınar | Zendy; İpek Genç | Zendy; Süleyman Kaleli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia

Author(s) -

Gamze Güney Eskiler,

Erhan BEZDEGÜMELİ,

Zeynep Özman,

Asuman Deveci Özkan,

Cemil Bilir,

Bilge Nur Küçükakça,

Merve İnce,

Angela Men,

O. Aktas,

Y. E. Horoz,

Denizhan Akpınar,

İpek Genç,

Süleyman Kaleli

Publication year - 2019

Publication title -

bratislavské lekárske listy/bratislava medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.387

H-Index - 32

eISSN - 1336-0345

pISSN - 0006-9248

DOI - 10.4149/bll_2019_136

Subject(s) - cachexia , breast cancer , medicine , cancer , lung cancer , stat3 , oncology , gastroenterology , cancer research , signal transduction , biology , biochemistry

We investigated the changes in the IL-6 and STAT3 expression levels in cachectic and non-cachectic patients with gastric, lung and breast cancer and evaluated the association between IL-6 and STAT3 levels and cancer types in terms of cachexia condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research